Roxana S Dronca MD
Genitourinary Oncology, Hematologic Oncology, Melanoma
Associate Professor of Oncology Chair, Division of Hematology-Oncology Interim Deputy Director, Cancer Center Mayo Clinic Florida
Join to View Full Profile
4500 San Pablo Road SJacksonville, FL 32224
Dr. Dronca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2010
Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 2003 - 2007
Iuliu Hatieganu University of Medicine and PharmacyClass of 1997
Certifications & Licensure
FL State Medical License 2017 - 2026
MN State Medical License 2007 - 2024
MI State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2011 Jan 01
- Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma Start of enrollment: 2019 Jun 12
Publications & Presentations
PubMed
- Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial.Jacob J Orme, Henan Zhang, Prashanth Lingamaneni, Yohan Kim, Roxane Lavoie
Nature Communications. 2025-03-13 - 3 citationsA real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate canc...Osama Mosalem, Winston Tan, Alan H Bryce, Roxana S Dronca, Daniel S Childs
Prostate Cancer and Prostatic Diseases. 2025-03-01 - Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.Yan Luo, Martha E Gadd, Yaqing Qie, Andrea Otamendi-Lopez, Jesus E Sanchez-Garavito
Molecular Therapy. Oncology. 2024-12-19
Press Mentions
DeSantis’ Push to Shakeup Cancer Funding Could Be in Trouble in the HouseFebruary 26th, 2025- 2025 Could Be the Year in-Home Cancer Care Finally Takes OffJanuary 27th, 2025
- Is Home-Based Treatment the Future of Cancer Care?January 16th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
